Cargando…
Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR”
Autores principales: | Zhao, Li-Min, Qiu, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589698/ https://www.ncbi.nlm.nih.gov/pubmed/34805647 http://dx.doi.org/10.1016/j.ekir.2021.09.014 |
Ejemplares similares
-
Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
por: Arshad, Adam, et al.
Publicado: (2021) -
Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations”
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022) -
Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2023) -
Population Estimates of GFR and Risk Factors for CKD in Guatemala
por: Miller, Ann C., et al.
Publicado: (2021) -
Letter Regarding “Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes”
por: Volbeda, Meint, et al.
Publicado: (2023)